Musical Shares
2 weeks ago
I want to remind everyone and introduce to all those that are new a little bit about the CEO here.
For all that don't know, there use to be a company on the OTC called OWCP (One World Cannabis Pharmaceutical). It was a medical marijuana research company based out of Israel. The CEO at the time was Ziv Turner. Turner and Feldenkrais are friends.
Here is a press release from 2020 that includes the CEO of Can It Industries (eventually the shell of CATV):
https://www.otcmarkets.com/stock/OWCP/news/OWC-Pharmaceutical-Research-Corp-Announces-A-New-Distribution-Agreement-With-Can-It-Industries-Florida-US?id=273829
I want to point out some passages in their:
Ziv Turner, OWC CEO and Chairman comments: "I've shared and shaped OWC's vision and goals with Michael over the past 6 years, and I am excited and proud to join forces with Can It, while it's moving forward in the carefully crafted pharma-grade medical cannabis path.
This game of creating a medical marijuana research firm has been going on for over a decade. So, why is it where it is then?
Michael Feldenkrais, CEO of Can IT Industries, Inc. comments: "Can It is seeking to change the current guesswork involved in deciding how to treat disease using Medicinal Cannabis. Patients seeking to employ medicinal cannabis as a treatment are faced with unreliable cannabis products from most dispensaries and the uncertainty as to what compounds to use. As such the company has licensed and signed agreements with state of the art technologies like OWC and others that provide a 360 degree approach to achieve this goal."
"The company has been gathering formulations in 3rd Phase Clinical trials and distributing in the Western Hemisphere," Feldenkrais adds. "Our strategy considers the mitigation of the environmental risks involved in cultivation of Cannabis by using the correct genetics to create the best medicines for individualized treatment."
Feldenkrais continues: "Can IT accomplishes its goals in three steps: assembling the most current and proven medicinal cannabis research and clinical studies. Second, it leverages both pre-eminent medicinal cannabis experts and machine learning platforms to analyze data and standardize medicinal cannabis compounds. Third, Can IT uses proven data and expert analysis to develop validated personalized medicinal cannabis treatment recommendations for our patient-members and their healthcare providers and enable access to reliable partner dispensaries to obtain the proper cannabis compound ratios and dosages. We are proud to announce our agreement with OWC as part of our strategy to achieve our goals."
You are all being fooled here. 10 years later and this is how far this has all come?
What makes no sense is... if this was all happening years ago, then why has none of this ever been talked about in the last 4 years of CATV? Why did he just now start talking about being a cannabis biotech?
If this was all so great, then why wouldn't Turner and him keep doing things in Israel? After all, cannabis research in Israel is much less strict than anywhere else in the world.
None of this makes any sense.
BigBadWolf
2 weeks ago
No change nSS Authorized Shares 5,000,000,000 07/04/2024
Outstanding Shares 4,328,096,670 07/04/2024
Restricted 296,187,622 07/04/2024
Unrestricted 4,031,909,048 07/04/2024
Held at DTC 2,807,634,428 07/04/2024
SS N/C last trading week Authorized Shares 5,000,000,000 07/02/2024
Outstanding Shares 4,328,096,670 07/02/2024
Restricted 296,187,622 07/02/2024
Unrestricted 4,031,909,048 07/02/2024
Held at DTC 2,807,634,428 07/02/2024
Authorized Shares 5,000,000,000 06/24/2024
Outstanding Shares 4,328,096,670 06/24/2024 >44,919,500
Restricted 296,187,622 06/24/2024 >374,046
Unrestricted 4,031,909,048 06/24/2024 >44,545,454
Held at DTC 2,807,634,428 06/24/2024
Authorized Shares 5,000,000,000 06/16/2024
Outstanding Shares 4,283,177,170 06/16/2024
Restricted 295,813,576 06/16/2024
Unrestricted 3,987,363,594 06/16/2024
Held at DTC 2,807,634,428 06/16/2024
BigBadWolf
3 weeks ago
SS N/C last trading week Authorized Shares 5,000,000,000 07/02/2024
Outstanding Shares 4,328,096,670 07/02/2024
Restricted 296,187,622 07/02/2024
Unrestricted 4,031,909,048 07/02/2024
Held at DTC 2,807,634,428 07/02/2024
Authorized Shares 5,000,000,000 06/24/2024
Outstanding Shares 4,328,096,670 06/24/2024 >44,919,500
Restricted 296,187,622 06/24/2024 >374,046
Unrestricted 4,031,909,048 06/24/2024 >44,545,454
Held at DTC 2,807,634,428 06/24/2024
Authorized Shares 5,000,000,000 06/16/2024
Outstanding Shares 4,283,177,170 06/16/2024
Restricted 295,813,576 06/16/2024
Unrestricted 3,987,363,594 06/16/2024
Held at DTC 2,807,634,428 06/16/2024